Minor Cannabinoids by the Numbers

Exploring the Growing Impact of Rare Cannabinoids

Jan 14, 2025

As the cannabis industry matures, minor cannabinoids are beginning to take center stage. Once overshadowed by the more common cannabinoids like THC and CBD, these lesser-known compounds are now recognized for their unique benefits and market potential. Data and trends show that minor cannabinoids, including THCV, CBC, and CBN, are transforming various categories, from edibles to vapes and even flower,, indicating that businesses and consumers alike are ready to explore what these rare compounds offer.

1. Rising Demand for Minor Cannabinoids

According to recent market data, the demand for minor cannabinoids has surged, driven largely by growing consumer awareness and the continuous search for innovative health solutions. As reported in BayMedica’s latest market analysis, consumer interest is motivated by minor cannabinoids’ non-intoxicating properties and diverse health and wellness applications. This trend is expected to grow as more research highlights the benefits of compounds like THCV for energy and appetite control, CBC for mood-enhancing properties, and CBN for relaxation and sleep.

In 2024, the market for edibles infused with minor cannabinoids experienced notable growth, especially in segments targeting functional and wellness products. Minor cannabinoid-infused edibles now comprise a significant portion of the overall cannabis edibles market, reflecting a fundamental shift in product development in response to consumers’ appetite for a predictable experience with specialized effects.

Want to dive deeper into the growth trends driving minor cannabinoids in the market? Download our comprehensive 2024 Market Report for exclusive insights.

2. THCV: A Game-Changer in Weight Management and Energy Boosts

One of the most studied minor cannabinoids, tetrahydrocannabivarin (THCV), shows promising applications for weight management, energy, and metabolic health. Unlike THC, THCV is non-intoxicating and has demonstrated appetite-suppressing effects, making it a potential game-changer for health-conscious consumers. Studies reveal that THCV interacts with the endocannabinoid system differently from THC, potentially reducing cravings and increasing energy expenditure without the “high” associated with traditional cannabis products.

This unique profile has attracted the attention of health and wellness brands and medical researchers, with clinical studies exploring its efficacy for obesity and metabolic disorders. As THCV gains popularity, brands offering THCV-infused products are likely to benefit from its unique appeal and applications.

3. Cannabichromene (CBC): Mood-enhancing Properties

Cannabichromene (CBC) is another minor cannabinoid with distinct properties that are drawing industry interest. Recognized for its potential in mood-enhancing applications and its ability to help ameliorate the aches and pains of daily living, CBC has gained traction in edibles for its blissful effects. CBC’s qualities indicate potential applications in relief from discomfort and stress as well as mental health support. It is also widely recognized for its ability to mitigate the dysphoria some experience when consuming THC. Unlike THC, CBC does not bind to the primary endocannabinoid receptors responsible for psychoactivity, making it a favorable option for consumers seeking therapeutic benefits without intoxication. This profile has increased CBC’s utilization of an array of cannabinoid products across the natural wellness market, especially in ingestible forms for targeted health benefits.

4. Cannabinol (CBN): The Sleep and Relaxation Aid

While other cannabinoids focus on energy or inflammation, cannabinol (CBN) is known primarily for its sedative effects. This characteristic has made CBN a popular choice for sleep and relaxation products. The growing need for non-habit-forming sleep aids has given CBN an edge in the wellness industry, as it provides a natural alternative to over-the-counter sleep medications. CBN products, including tinctures, gummies, and capsules, now occupy a prominent place in the cannabis market as brands highlight their soothing effects for sleep support.

CBN’s popularity is largely driven by a shift in consumer preferences toward non-pharmaceutical, gentle solutions for sleep disorders. With the sleep aid market projected to grow significantly over the coming years, CBN’s place in the cannabinoid landscape is expected to expand as consumers seek safer alternatives for improving sleep quality.

5. Regulatory Landscape and Market Forecast

As the minor cannabinoid market expands, the regulatory environment will continue to play a crucial role in shaping industry trends. Many minor cannabinoids, including THCV and CBC, benefit from a favorable regulatory status under the 2018 Farm Bill, which allows for their sale in nationally distributed, low-THC cannabis products. However, ongoing research and development are needed to better understand each cannabinoid’s effects, optimal dosages, and safety profiles.

Industry experts project that the minor cannabinoid sector will experience continued growth, with North America and Europe being key markets. Within the U.S., where regulations vary by state, brands that can navigate these complexities will likely capitalize on the demand for differentiated products. Companies like BayMedica, specializing in producing high-purity minor cannabinoids through synthesized and biosynthetic processes, are well-positioned to meet rising demand with reliable and scalable production solutions.

6. Key Takeaways for Businesses

For brands in the cannabis space, now is the ideal time to consider incorporating minor cannabinoids into their product lines. These compounds not only diversify offerings but also appeal to an increasingly educated consumer base that values specific, targeted health benefits over general wellness claims. From sleep aids to pain relief and mood enhancement, minor cannabinoids offer unique advantages that resonate with today’s health-conscious consumers.

Broad Appeal: Minor cannabinoids appeal across demographics, with health-conscious consumers seeking non-intoxicating options.
Scalability and Cost-Effectiveness: Advances in biosynthetic and chemical synthesis processes make it feasible to produce minor cannabinoids at scale, reducing costs and improving accessibility.
Differentiated Products: Minor cannabinoid formulations offer opportunities for product innovation, allowing brands to differentiate in a crowded CBD and THC market.

Conclusion: The Future of Minor Cannabinoids

The trajectory for minor cannabinoids is clear: as scientific research continues to unveil their potential benefits, consumer demand is set to grow, pushing brands to explore these rare compounds further. Businesses that embrace this trend and invest in minor cannabinoid innovation will likely see rewards as they cater to a market that values science-backed, specialized cannabinoid solutions.

Explore the latest insights on the expanding edibles and minor cannabinoid market by downloading our 2024 Edibles Market Report. This comprehensive report offers in-depth data and analysis to help your business stay ahead in the rapidly evolving cannabinoid market.